ADJUVANT NITROSOUREA THERAPY FOR GLIOBLASTOMA

被引:40
作者
BRISMAN, R
HOUSEPIAN, EM
CHANG, C
DUFFY, P
BALIS, E
机构
[1] COLUMBIA PRESBYTERIAN MED CTR,NEW YORK NEUROL INST,NEW YORK,NY 10032
[2] COLUMBIA UNIV,COLL PHYS & SURG,BRAIN TUMOR STUDY GRP,NEW YORK,NY 10032
关键词
D O I
10.1001/archneur.1976.00500110013003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:745 / 750
页数:6
相关论文
共 21 条
[1]  
BAND PR, 1974, P AM ASSOC CANC RES, V15, P161
[2]  
BARKER M, 1973, CANCER RES, V33, P976
[3]   GLIOBLASTOMA MULTIFORME - CONTROLLED TRIAL TO ASSESS VALUE OF SPECIFIC ACTIVE IMMUNOTHERAPY IN PATIENTS TREATED BY RADICAL SURGERY AND RADIOTHERAPY [J].
BLOOM, HJG ;
PECKHAM, MJ ;
RICHARDSON, AE ;
ALEXANDER, PA ;
PAYNE, PM .
BRITISH JOURNAL OF CANCER, 1973, 27 (03) :253-267
[4]  
Brisman R, 1968, N Engl J Med, V279, P1289
[5]  
ELVIDGE AR, 1935, P ASSOC NERV MENT DI, V16, P107
[6]  
FEWER D, 1972, CANCER CHEMOTH REP 1, V56, P421
[7]  
IRIARTE PV, 1966, CANCER, V19, P1187, DOI 10.1002/1097-0142(196609)19:9<1187::AID-CNCR2820190902>3.0.CO
[8]  
2-T
[9]   GLIOBLASTOMA MULTIFORME - ITS TREATMENT AND SOME FACTORS EFFECTING SURVIVAL [J].
JELSMA, R ;
BUCY, PC .
ARCHIVES OF NEUROLOGY, 1969, 20 (02) :161-&
[10]  
MAYO JG, 1972, CANCER CHEMOTH REP 1, V56, P183